Polypharmacy is associated with treatment response and serious adverse events: results from the British Society for Rheumatology Biologics Register for Rheumatoid Arthritis
ConclusionPolypharmacy is a simple but valuable predictor of clinical outcomes in patients with RA. This study supports medication count as a valid measure for use in epidemiologic analyses.
Source: Rheumatology - Category: Rheumatology Source Type: research
More News: Arthritis | Epidemiology | Rheumatoid Arthritis | Rheumatology | Statistics | Study | UK Health